to making your patient experience one in which you feel free to ask questions about your procedure, medications and healthcare treatments. We are dedicated to providing you with high quality care.
New England Compounding Center Update
On October 4, 2012, the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) began coordinating a nationwide investigation of patients who had contracted fungal meningitis after receiving a steroid medication administered by injection for disorders of the spine. The medication identified as the cause of the outbreak, methylprednisolone acetate, was produced at the New England Compounding Center (NECC) located in Framingham, Massachusetts. The CDC and the FDA have been closely monitoring this situation and working with healthcare providers throughout the country to ensure that the public is as protected as possible.
In cooperation with the State of Hawaii Department of Health, the FDA, and the CDC, Surgicare of Hawaii immediately removed all medications obtained from NECC from use. In addition, NO steroid medication identified as the source for the meningitis outbreak was within our facility at ANY time. It is our goal to keep our patients as informed and safe as possible regarding these developments.